SA ready to lead COVID-19 vaccine production
South Australia is uniquely placed to play a vital role in expediting the nation鈥檚 COVID-19 vaccine rollout.
The state has the capability to produce mRNA vaccines, similar to the Pfizer vaccine against COVID-19, within 12 months at a local advanced manufacturing facility. The initiative would be driven by international biotech company BioCina, leveraging the complementary research, technological and clinical trials expertise of the University of 亚洲色吧 and SAHMRI.
BioCina CEO Ian Wisenberg says the university and medical research institute鈥檚 strengths were a key factor in his company鈥檚 recent decision to purchase Pfizer鈥檚 biologics manufacturing plant at Thebarton.
鈥淭he facility itself is a gem and the people make it shine,鈥 Mr Wisenberg said.
鈥淩esearch and talent are key to the success of our industry and here we have them right on our doorstep. Many of our colleagues were educated at the University.
鈥淭he 4600m2 plant was founded by the University of 亚洲色吧 and under the stewardship of Pfizer and Hospira has more than 35 years鈥 experience with microbial fermentation. It is the most advanced facility of its kind in Australia and the only one approved by the US-FDA.鈥